The DOI matches its Crossref record; 29 of the 30 references it cites were found in a registry or an index.
Endovascular ultrasound renal denervation to treat hypertension (RADIANCE-HTN SOLO): a multicentre, international, single-blind, randomised, sham-controlled trial
Open accessAbstract
BACKGROUND: Early studies suggest that radiofrequency-based renal denervation reduces blood pressure in patients with moderate hypertension. We investigated whether an alternative technology using endovascular ultrasound renal denervation reduces ambulatory blood pressure in patients with hypertension in the absence of antihypertensive medications. METHODS: RADIANCE-HTN SOLO was a multicentre, international, single-blind, randomised, sham-controlled trial done at 21 centres in the USA and 18 in Europe. Patients with combined systolic-diastolic hypertension aged 18-75 years were eligible if they had ambulatory blood pressure greater than or equal to 135/85 mm Hg and less than 170/105 mm Hg after a 4-week discontinuation of up to two antihypertensive medications and had suitable renal artery anatomy. Patients were randomised (1:1) to undergo renal denervation with the Paradise system (ReCor Medical, Palo Alto, CA, USA) or a sham procedure consisting of renal angiography only. The randomisation sequence was computer generated and stratified by centres with randomised blocks of four or six and permutation of treatments within each block. Patients and outcome assessors were blinded to randomisation. The primary effectiveness endpoint was the change in daytime ambulatory systolic blood pressure at 2 months in the intention-to-treat population. Patients were to remain off antihypertensive medications throughout the 2 months of follow-up unless specified blood pressure criteria were exceeded. Major adverse events included all-cause mortality, renal failure, an embolic event with end-organ damage, renal artery or other major vascular complications requiring intervention, or admission to hospital for hypertensive crisis within 30 days and new renal artery stenosis within 6 months. This study is registered with ClinicalTrials.gov, number NCT02649426. FINDINGS: Between March 28, 2016, and Dec 28, 2017, 803 patients were screened for eligibility and 146 were randomised to undergo renal denervation (n=74) or a sham procedure (n=72). The reduction in daytime ambulatory systolic blood pressure was greater with renal denervation (-8·5 mm Hg, SD 9·3) than with the sham procedure (-2·2 mm Hg, SD 10·0; baseline-adjusted difference between groups: -6·3 mm Hg, 95% CI -9·4 to -3·1, p=0·0001). No major adverse events were reported in either group. INTERPRETATION: Compared with a sham procedure, endovascular ultrasound renal denervation reduced ambulatory blood pressure at 2 months in patients with combined systolic-diastolic hypertension in the absence of medications. FUNDING: ReCor Medical.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In all three trials, RDN reduced blood pressure relative to a sham procedure, resulting in an approximately 6-mmHg decrease in daytime ambulatory SBP.”
From Renal nerves in physiology, pathophysiology and interoception (2025) · cites this paper as [12]
Experimental — accuracy not yet measuredIn the citing paper
“In overweight patients with hypertension who were not taking antihypertensive medications, endovascular ultrasound RDN caused significantly greater reductions in 24-hour ambulatory systolic BP at 2 months than did a sham procedure166.”
From Obesity, kidney dysfunction and hypertension: mechanistic links (2019) · cites this paper as [166]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED: Relationship between Clinic and Ambulatory Blood-Pressure Measurements and Mortality
Banegas, J. R., Ruilope, L. M., de la Sierra, A., Vinyoles, E., Gorostidi, M., de la Cruz, J. J., Ruiz-Hurtado, G., Segura, J., Rodríguez-Artalejo, F., & Williams, B. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1712231 · Cited by 490
RetractedEttehad, D., Emdin, C. A., Kiran, A., Anderson, S. G., Callender, T., Emberson, J., Chalmers, J., Rodgers, A., & Rahimi, K. (2016) · The Lancet · doi:10.1016/s0140-6736(15)01225-8 · Cited by 3,755
A Controlled Trial of Renal Denervation for Resistant Hypertension
Bhatt, D. L., Kandzari, D. E., O'Neill, W. W., D'Agostino, R., Flack, J. M., Katzen, B. T., Leon, M. B., Liu, M., Mauri, L., Negoita, M., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1402670 · Cited by 2,186
Self-citationClinical applications of visual analogue scales: a critical review
McCormack, H. M., Horne, D. J. D. L., & Sheather, S. J. (1988) · Psychological Medicine · doi:10.1017/s0033291700009934 · Cited by 2,108
Krum, H., Schlaich, M., Whitbourn, R., Sobotka, P. A., Sadowski, J., Bartus, K., Kapelak, B., Walton, A., Sievert, H., Thambar, S., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60566-3 · Cited by 2,108
Townsend, R. R., Mahfoud, F., Kandzari, D. E., Kario, K., Pocock, S., Weber, M. A., Ewen, S., Tsioufis, K., Tousoulis, D., Sharp, A. S. P., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32281-x · Cited by 752
Self-citationAssessment of blinding in clinical trials
Bang, H., Ni, L., & Davis, C. E. (2004) · Controlled Clinical Trials · doi:10.1016/j.cct.2003.10.016 · Cited by 682
Krum, H., Schlaich, M. P., Sobotka, P. A., Böhm, M., Mahfoud, F., Rocha‐Singh, K. J., Katholi, R. E., & Esler, M. (2013) · The Lancet · doi:10.1016/s0140-6736(13)62192-3 · Cited by 622
Self-citationAzizi, M., Sapoval, M., Gosse, P., Monge, M., Bobrie, G., Delsart, P., Midulla, M., Mounier-Véhier, C., Courand, P.-Y., Lantelme, P., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61942-5 · Cited by 519
Self-citation
Cited by
Sorted by citations
Items 701–738 of 738
Makris, A., Soulaidopoulos, S., Sagris, Μ., Platanias, K., Kyriakoulis, K., Konstantinidis, D., Tatakis, F., Gompos, G., Dimitriadis, K. S., Kordalis, A., et al. (2026) · Catheterization and Cardiovascular Interventions · doi:10.1002/ccd.70600
Aorticorenal Ganglion Ablation Enhances Blood Pressure Reduction After Renal Denervation
Long, Y., Lai, Y., Ren, Y., Ma, X., Li, D., Chen, L., Liao, X., Xia, T., Liu, Z., Ling, Z., et al. (2026) · Hypertension · doi:10.1161/hypertensionaha.125.26719
Yoon, M., Kim, H., Han, J. H., Kim, H. J., Jeong, C. W., & Choi, D. (2026) · Clinical Hypertension · doi:10.5646/ch.2026.32.e18
Modern Device-based Renal Denervation Approach for the Management of Uncontrolled Hypertension
Gopi, A., Rao, S. A. R. I. T. A., Sinha, N., Mehta, N., Nadkar, M., & TIWASKAR, M. H. (2026) · Journal of the Association of Physicians of India · doi:10.59556/japi.74.1468
Renal denervation: from establishing effectiveness to measuring success
Lee, H., Krawisz, A. K., & Secemsky, E. A. (2026) · Current Opinion in Cardiology · doi:10.1097/hco.0000000000001299
Aires, R. S., Silva, M. D. C. C., Barbosa, F. D. M., da Silva, M. C., Alves, S. M. D. L., Araújo, A. V., & de Queiroz, T. M. (2026) · Pharmaceuticals · doi:10.3390/ph19050676
Nouvelles cibles thérapeutiques dans l’hypertension artérielle
Kantor, B. (2026) · Archives des Maladies du Coeur et des Vaisseaux - Pratique · doi:10.1016/j.amcp.2026.04.002
Recent update on renal denervation: where do we stand now?
Shin, J., & Yoon, Y.-W. (2026) · Clinical Hypertension · doi:10.5646/ch.2026.32.e26
Management Strategies for Treatment-Resistant Hypertension: Current Status and Future Outlook
Thakare, S. B., Anandh, U., & Dasgupta, I. (2026) · Indian Journal of Nephrology · doi:10.25259/ijn_658_2025
Gao, X., Fu, Z., Wang, Z., Lv, Z., & Zhang, W. (2026) · Frontiers in Neuroscience · doi:10.3389/fnins.2026.1836903
Li, M., Yang, D., Cheng, X., Wei, Q., & Zhang, D. (2026) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2026.1844520
Phenotype-Guided Renal Denervation: the Key to Therapeutic Response
Shahverdi, E., Herda, L. R., Shahi, S., Lange, M., & Schneider, C. (2026) · High Blood Pressure & Cardiovascular Prevention · doi:10.1007/s40292-026-00809-1
Liu, C., Lin, M. T., Xu, F., Yan, Y., & Tao, L. (2026) · Frontiers in Public Health · doi:10.3389/fpubh.2026.1801333
Silva, J. D., Cunha, V., Nogueira‐Silva, L., Calé, R., Abecasis, F., Batista, G., Bastos, J. M., Almeida, M., & Gonçalves, F. M. (2026) · Revista Portuguesa de Cardiologia · doi:10.1016/j.repc.2026.03.011
Special Issue: Recent Research on Hypertension and Related Complications
Delrue, C., & Speeckaert, M. M. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27136031
Antihypertensive Treatment in Chronic Kidney Disease: Current Algorithms
Theodorakopoulou, M. P., & Sarafidis, P. A. (2026) · Updates in hypertension and cardiovascular protection · doi:10.1007/978-3-032-29564-4_12
Refractory arterial hypertension: important, but suboptimally characterized
Koracevic, G. P., Stojanovic, M., Zdravkovic, M., Otasevic, S., Zdravković, M., Randjelovic, M., Lazarević, G., & Pavlović, D. A. (2026) · Current Medical Research and Opinion · doi:10.1080/03007995.2026.2706900
Blood pressure and renal outcomes after renal denervation in patients with chronic kidney disease
Malik, J., Baig, S., Subhan, M., Sandesh, F., Kumari, P., & Perveen, A. (2026) · Medicine · doi:10.1097/md.0000000000050220
Indian Guidelines on Hypertension (I.G.H.)-V. 2025–2026
Mehta, N., Mathur, G., Pal, J., Taneja, A., Wander, G. S., Pareek, K. K., Narsimulu, G., Saxena, P., Muruganathan, A., Chattetjee, N., et al. (2026) · Journal of the Association of Physicians of India · doi:10.59556/japi.74.1495
Skalidis, I., Koliastasis, L., Vlachakis, P. K., Apostolos, A., Bozika, M., Nastouli, K.-M., Amabile, N., Garot, P., Hovasse, T., Akodad, M., et al. (2026) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd13090443
Renal denervation for hypertension management: past, current evidence, and future directions
Hassan, S., Rendon, I. H., Spilias, N., Bredel, L., Chatzizisis, Y. S., & Delgado-Lelievre, M. C. (2026) · American Journal of Hypertension · doi:10.1093/ajh/hpag112
From endovascular therapy to perivascular therapy: A new concept and perspective
Wang, Z., Shi, P., Zhou, Y.-J., Guo, W., Cao, Y., Mao, S., & Teng, G.-J. (2026) · EngMedicine · doi:10.1016/j.engmed.2026.100164
Balloon-integrated binary acoustic lens for energy localisation in ultrasound renal denervation
Zhao, W., Wu, Y., Ji, M., Shen, L., Cui, Z., Yao, Z., Wang, C., Qian, J., & Ge, J. (2026) · Results in Engineering · doi:10.1016/j.rineng.2026.113050
Treatment-resistant hypertension in the primary care setting
Joshi, V., Mangalgi, S., Chaudhary, K., & Whaley‐Connell, A. T. (2026) · Journal of Osteopathic Medicine · doi:10.1515/jom-2026-0011
Renal Denervation via Left Transradial Artery Approach to Circumvent Infrarenal Aortic Tortuosity
Saha, A., Palkhiwala, S., Rao, S. V., & Razzouk, L. (2026) · Catheterization and Cardiovascular Interventions · doi:10.1002/ccd.70912
The role of immuno-inflammatory biomarkers in the pathogenesis of hypertension
Mordovin, V. F., Rudenko, V. V., Zyubanova, I. V., Lichikaki, V. A., Manukyan, M. A., Хунхинова, С. А., Цой, Е. И., Popova, A. A., Вторушина, А. А., Garganeeva, E. S., et al. (2026) · Arterial’naya Gipertenziya (Arterial Hypertension) · doi:10.18705/1607-419x-2026-2593
Emerging therapeutics in hypertension: Evidence, clinical readiness, and implementation
Tavethia, J., Gowda, D. A. S., Mehta, S., Kaur, B., Ghay, P., Ghay, S., Chowdhary, R., Kulkarni, K., Bhadania, A., Sharma, K. H., et al. (2026) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2026.103470
Early blood pressure outcomes after SPYRAL™ renal denervation: an exploratory small cohort analysis
Stanisavljevikj, S., Anwar, A., Rumman, A. S. A., Alagjozovski, H., Kavalerchyk, V., Bojovski, I., Vukadinović, D., Weil, J., & Staudt, A. (2026) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2026.1934448
Comparative Efficacy of Treatments for Resistant or Uncontrolled Hypertension
Laino, A., Piccolo, R., Vitale, A. P., Izzo, R., Franzone, A., & Esposito, G. (2026) · JACC Advances · doi:10.1016/j.jacadv.2026.103306
Davis, L. L., Yang, E., Blyler, C. A., Cluett, J., Cohen, J. B., Juraschek, S. P., Reilly, J. P., & Tobb, K. (2026) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2026.08.028
Self-citationRenal denervation beyond resistant hypertension: should drug intolerance redefine eligibility?
Cordeanu, E., Morisot, E., Mirea, C., Prinz, É., Bronner, F., & Stéphan, D. (2026) · International Journal of Cardiology Cardiovascular Risk and Prevention · doi:10.1016/j.ijcrp.2026.200717
Yamamoto, E., Izumiya, Y., & Tsujita, K. (2026) · Cardiovascular Intervention and Therapeutics · doi:10.1007/s12928-026-01353-4
Choudhary, A. K., Hait, A., & Baladaniya, M. (2026) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2026.1958980
Tang, Y., Yao, J., Chen, Y., Jian, Y., Chen, T., Yang, Z., & Li, M. (2026) · Medical Review · doi:10.1515/mr-2026-0057
Evaluating Patients for Renal Denervation: A Pragmatic Approach
Delgado-Lelievre, M. C., Azizi, M., & Fisher, N. D. L. (2026) · Hypertension · doi:10.1161/hypertensionaha.126.27563
Self-citationMazza, A., Rossi, L., Bilato, C., Morani, G., Zanella, M., Iurilli, V., Danzi, V., Rigo, A., Presotto, F., Manfellotto, D., et al. (2026) · Italian Journal of Medicine · doi:10.4081/itjm.2026.2633
Henney, A. E., Anson, M., Riley, D. R. J., Fauchier, L., Giblett, J. P., Lip, G. Y. H., Malik, R. A., Cuthbertson, D. J., & Alam, U. (2026) · Diabetes Obesity and Metabolism · doi:10.1111/dom.71421
Schmieder, R. E., Kannenkeril, D., Böhm, M., Mahfoud, F., Rump, L. C., Stegbauer, J., van der Giet, M., Meyer, M. R., Schiffer, M., Veelken, R. A., et al. (2026) · Journal of Hypertension · doi:10.1097/hjh.0000000000004482
Self-citation
Metadata
- Authors
- Azizi, M., Schmieder, R. E., Mahfoud, F., Weber, M. A., Daemen, J., Davies, J., Basile, J., Kirtane, A. J., Wang, Y., Lobo, M. D., Saxena, M., Feyz, L., Rader, F., Lurz, P., Sayer, J., Sapoval, M., Levy, T., Sanghvi, K., Abraham, J., Sharp, A. S. P., Fisher, N. D. L., Bloch, M. J., Reeve-Stoffer, H., Coleman, L., Mullin, C., Mauri, L., Wang, Y., Jay, D., Skeik, N., Schwartz, R., Rader, F., Dohad, S., Victor, R., Sanghvi, K., Costello, J., Walsh, C., Abraham, J., Owan, T., Abraham, A., Fisher, N. D. L., Mauri, L., Sobieszczky, P., Williams, J., Bloch, M. J., Roongsritong, C., Todoran, T., Basile, J., Powers, E., Hodskins, E., Fong, P., Laffer, C., Gainer, J., Robbins, M., Reilly, J. P., Cash, M., Goldman, J., Aggarwal, S., Ledley, G., Hsi, D., Martin, S., Portnay, E., Calhoun, D., McElderry, T., Maddox, W., Oparil, S., Huang, P.-H., Jose, P., Khuddus, M., Zentko, S., O'Meara, J., Barb, I., Garasic, J., Drachman, D., Zusman, R., Rosenfield, K., Devireddy, C., Lea, J., Wells, B., Stouffer, R., Hinderliter, A., Pauley, E., Potluri, S., Biedermann, S., Bangalore, S., Williams, S., Zidar, D., Shishehbor, M., Effron, B., Costa, M., Kirtane, A. J., Radhakrishnan, J., Lobo, M. D., Saxena, M., Mathur, A., Jain, A., Sayer, J., Iyer, S. G., Robinson, N., Edroos, S. A., Levy, T., Patel, A., Beckett, D., Bent, C., Davies, J., Chapman, N., Shun-Shin, M., Howard, J., Sharp, A. S. P., Joseph, A., D'Souza, R., Gerber, R., Faris, M., Marshall, A. J., Elorz, C., Lurz, P., Höllriegel, R., Fengler, K., Rommel, K.-P., Mahfoud, F., Böhm, M., Ewen, S., Lucic, J., Schmieder, R. E., Ott, C., Schmid, A., Uder, M., Rump, L. C., Stegbauer, J., Kröpil, P., Azizi, M., Sapoval, M., Cornu, E., Fouassier, D., Gosse, P., Cremer, A., Trillaud, H., Papadopoulos, P., Pathak, A., Honton, B., Lantelme, P., Berge, C., Courand, P.-Y., Daemen, J., Feyz, L., Blankestijn, P. J., Voskuil, M., Rittersma, Z., Kroon, A. A., van Zwam, W. H., Persu, A., & Renkin, J.
- Affiliations
- State University of New York (US)
- ReCor Medical (United States) (US)
- NewYork–Presbyterian Hospital (US)
- University of Utah (US)
- University of Nevada, Reno (US)
- Lyon 1 Université (FR)
- ORCID
- Weber, Michael A
- Skeik, Nedaa
- Dohad, Suhail
- Walsh, Courtney
- Owan, Theophilus
- Williams, Jonathan
- Roongsritong, Chanwit
- Todoran, Thomas
- Powers, Eric
- Fong, Pete
- Laffer, Cheryl
- Reilly, John P.
- Aggarwal, Sandeep
- Hsi, David
- Calhoun, David
- Oparil, Suzanne
- Jose, Powell
- Rosenfield, Kenneth
- Devireddy, Chandan
- Lea, Janice
- Wells, Bryan
- Potluri, Srinivasa
- Bangalore, Sripal
- Shishehbor, Mehdi
- Mathur, Anthony
- Edroos, Sadat Ali
- Patel, Amit
- Bent, Clare
- Shun-Shin, Matthew
- Howard, James
- D'Souza, Richard
- Fengler, Karl
- Rommel, Karl-Philipp
- Böhm, Michael
- Ewen, Sebastian
- Schmid, Axel
- Uder, Michael
- Rump, L. Christian
- Stegbauer, Johannes
- Fouassier, David
- Gosse, Philippe
- Trillaud, Hervé
- Papadopoulos, Panteleimon
- Pathak, Atul
- Honton, Benjamin
- Lantelme, Pierre
- Courand, Pierre-Yves
- Blankestijn, Peter J.
- Voskuil, Michiel
- Kroon, A.A.
- Persu, Alexandre
- Venue
- The Lancet
- Publisher
- Elsevier BV
- Published
- 2018-06
- Volume
- 391
- Issue
- 10137
- Pages
- 2335-2345
- ISSN
- 0099-5355 (ISSN-L)
- 0140-6736
- OpenAlex
- W2803910972
- Cited by
- 740
- References
- 30
- Citations by year
- 2026: 56 · 2025: 67 · 2024: 88 · 2023: 105 · 2022: 94 · 2021: 101 · 2020: 91 · 2019: 96 · 2018: 41
- FWCI
- 62.23
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- The Lancet (publishedVersion, other-oa)
- PubMed (publishedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (publishedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
- HAL (submittedVersion)
- HAL (submittedVersion, cc-by-nc-nd)
- Utrecht University Repository (Utrecht University) (submittedVersion, other-oa)
- Royal Devon and Exeter Research Repository (Royal Devon and Exeter) (submittedVersion)
- Funders
- ReCor Medical
- National Institute for Health and Care Research (CL-2018-21-001)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
- Health Sciences › Medicine › Nephrology › Renal and Vascular Pathologies
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Disease Prevention
- Keywords
- hypertension, ambulatory blood pressure, radiofrequency renal denervation, antihypertensive medication withdrawal, renal artery stenosis, major adverse events, hypertensive crisis, renal failure, embolic events
- MeSH terms
- Adolescent, Adult, Aged, Denervation, Female, Humans, Hypertension, Kidney, Male, Middle Aged, Renal Artery, Ultrasonography, Single-Blind Method, Treatment Outcome, Blood Pressure Monitoring, Ambulatory, Young Adult, Endovascular Procedures
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review